0(543) 254 1144
İçindekiler
However, excess fat causes functional and structural changes in the liver. Liver fat can be associated with diseases that go with inflammation (inflammation) in the liver, or it can cause inflammation in the liver itself.
As a result, liver cells (hepatocytes) damage and liver fibrosis develops. As necrosis (cell destruction and death) in the liver progresses, the event develops into liver cirrhosis and can become a serious condition. Therefore, patients with advanced fatty liver should be carefully evaluated and followed closely.
Benign hepatosteatosis (benign fatty liver) refers to the accumulation of lipid (fat) droplets in liver cells (hepatocytes). The term hepatitis is a term denoting the inflammation (inflammation) of liver cells and the resulting cell damage. Steatohepatitis (steatosis = adiposity, steatohepatitis = fatty inflammation) means inflammation caused by the accumulation of fat in the liver. Although rare, benign hepatosteatosis can turn into steatohepatitis (8-20%). Likewise, fatty liver and inflammation of the liver as a result of alcohol use are also called alcoholic hepatitis.
Since steatohepatitis can be seen in people who have never consumed alcohol, it is called non-alcoholic fatty hepatitis (non-alcoholic – steato – hepatitis, NASH). NASH is a term used to describe the clinical syndrome in patients with liver biopsy found to have fatty and inflammation and no other cause of liver disease has been shown.
Steatohepatitis can lead to severe liver damage and cirrhosis. It is known that 10-20% of patients with NASH may develop liver cirrhosis. Studies have shown that steatohepatitis can develop in people who are overweight, lose weight quickly, use estrogen hormone, and diabetics whose blood sugar is not under control.
Steatohepatitis in fatty liver The liver plays an important role in the metabolism and destruction of fats in our body. Disruptions during the metabolism of fats in the liver can cause fat accumulation in the liver.
Metabolism or secretion of fats in the liver is closely related to the capacity of circulating fatty acids to be retained by fat stores in other tissues. In hepatic steatosis, fat secretion from the liver is impaired.
When the amount of carbohydrates coming to it increases, the liver spends the excess carbohydrates by converting them to fatty acids. Fatty acids released from the liver but not metabolized are reesterified in the liver and triglycerides are formed again. Excess carbohydrate intake in the diet leads to fat accumulation in the liver.
The most common form of fatty liver is the type that occurs during the course of other diseases. The most well-known of these is obesity. Fatty liver is detected in 2/3 of people whose body weight is more than 10% of normal.
Apart from this, diabetes (especially type 2 diabetes mellitus), hypertriglyceridemia (high triglyceride levels in the blood) and excessive alcohol use are other common conditions that can lead to fatty liver. High blood lipid cholesterol alone is not a risk factor for fatty liver.
Excessive use of vitamin A, long-term intravenous nutrition, rapid weight loss and corticosteroids, etc. Long-term use of drugs can cause fatty liver. Although it seems logical that a diet with fatty foods can cause fatty liver, this type of diet does not cause fatty liver unless it leads to excessive weight gain and elevated blood triglyceride levels.
Fatty liver does not usually have symptoms that can be noticed by the patient. Symptoms such as weakness, fatigue, and pain or a feeling of fullness in the upper right part of the abdomen may be present.
In fact, it is often not possible to notice fatty liver during routine physical examination. Generally, it is understood that there is fatty liver with other tests performed upon detection of an increase in liver enzymes in blood tests performed for another reason.
Sometimes, during physical examination, it may be noticed that the liver has grown in a soft consistency, but it is understood that the liver has enlarged after ultrasonographic examination.
In practice, fatty liver is detected incidentally during the ultrasonographic examination performed to investigate another disease.
Although the definitive diagnosis of fatty liver is made by liver needle biopsy (under local anesthesia, a small piece of liver tissue is taken with a thin needle and examined under a microscope), except under very special conditions, needle biopsy is generally not required in people with fatty liver.
Lung fat is a disease that usually resolves and regresses when the underlying causes are eliminated. Treatment is usually done according to the cause of lubrication. For example; such as losing excess weight (obesity treatment), lowering high blood triglyceride levels, controlling diabetes, and cessation of alcohol use.
The coexistence of obesity (being overweight) with high blood triglyceride levels and diabetes can make the condition more serious. Patients who cannot lose weight with exercise and diet programs should be assisted with other methods, such as the insertion of a weakening gastric balloon (see attenuating gastric balloon). Liver transplantation is rarely needed in steatohepatitis.
Treatment of fatty liver depends on the cause. An overweight patient must lose weight and move. If he has diabetes, his sugar must be kept under good control.
If he uses alcohol, he must stop. If there is insulin resistance, he should use diet, sports and, if necessary, drug therapy to reduce insulin resistance.
Currently, there is no effective drug treatment for liver lubrication.
Adjunctive drug treatments may only be partially beneficial to halt the progression of the disease.
Leveraging is dangerous. Because fatty liver disease can cause a process that can lead to liver cirrhosis and cancer in some patients.
So protect your liver from fat.
